https://www.gov.uk/drug-safety-update/high-strength-fixed-combination-and-biosimilar-insulin-products-minimising-the-risk-of-medication-error?UNLID=7533607272016481362
Several new high strength insulin products are now on the market. The European Medicines Agency is consulting on guidance to minimise the risk of medication...
high strengthbiosimilar insulinfixedcombinationproducts
https://www.expertmarketresearch.com/reports/asia-pacific-biosimilar-insulin-glargine-and-lispro-market
APAC biosimilar insulin market grows with global rise. Global market to hit USD 9272.31 Million by 2035 from USD 2436.27 Million in 2025 at 14.30% CAGR.
biosimilar insulinapacglarginelispromarket